News

TechMARK movers: SkyePharma plunges

08 July 2008 11:31:00

Drug developer SkyePharma has lost a quarter of its value as investors grow impatient at the firm's failure to make progress with plans to renegotiate or refinance its convertible bonds.

The company had said in May that a proposal to key bondholders and definitive plans for the bonds were expected to be announced shortly after results of two pivotal phase III efficacy trials of asthma treatment Flutiform.

Positive top line results of both of trials have now been reported, but despite significant support for its plans, talks about the specific proposals for the bonds have been postponed due to "current capital market conditions".

Electronic Data Processing rallied after it confirmed late yesterday that it in early stage discussions regarding a possible offer for the IT solution provider from its management which may or may not lead to an offer being made for the company.

A further announcement will be made in due course as appropriate, the group added.

FTSE TechMARK - Fallers
Skyepharma (SKP) 3.80p -30.66%
Morse (MOR) 42.00p -17.65%
Kewill Systems (KWL) 80.50p -9.55%
Gresham Computing (GHT) 53.00p -8.62%
BATM Advanced (BVC) 47.00p -7.39%
Anite Group (AIE) 34.00p -6.85%
Trafficmaster (TFC) 31.00p -6.77%
BTG (BGC) 158.50p -6.76%
Psion (PON) 107.00p -6.14%
Axon Group (AXO) 403.00p -5.40%

FTSE TechMARK - Risers
Electronic Data Processing (EDP) 60.50p +13.08%
Parity Group (PTY) 24.00p +2.13%
Vtech (VTH) 262.50p +1.94%
Innovation Group (TIG) 18.00p +1.41%
Alizyme (AZM) 18.50p +1.37%
Corin Group (CRG) 112.75p +1.35%
Kofax (KFX) 183.25p +0.96%
SDL International (SDL) 292.75p +0.95%
Phoenix IT Group (PNX) 275.00p +0.92%

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.